We have shown that C2.01 impairs binding of La to specific mRNAs in cells and thereby mimics the effect of La depletion in head and neck cancer cells by reducing Bcl2 protein expression and sensitization to cisplatin. Here, BCL2 is linked to head and neck cancer.